Isnain, Sitti Farrah S.

HRN: 28-53-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/26/2026
08/02/2026
IV
590mg
Q6
ASA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: